We are live on
!
Find out more
PSC
Prentiss Smith & Co Portfolio holdings
AUM
$182M
1-Year Est. Return
26.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+26.44%
3 Year Est. Return
+63.89%
5 Year Est. Return
+57.29%
10 Year Est. Return
+270.91%
AUM
$195M
AUM Growth
-$15M
(-7.2%)
Cap. Flow
-$23.6M
Cap. Flow
% of AUM
-12.1%
Top 10 Holdings %
Top 10 Hldgs %
38.79%
Holding
80
New
3
Increased
10
Reduced
36
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dentsply Sirona
XRAY
|
+$3.91M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$2.39M |
| 3 |
Simpson Manufacturing
SSD
|
+$2.02M |
| 4 |
Becton Dickinson
BDX
|
+$1.2M |
| 5 |
AGR
Avangrid, Inc.
AGR
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idacorp
IDA
|
+$6.39M |
| 2 |
Medtronic
MDT
|
+$5.34M |
| 3 |
Brady Corp
BRC
|
+$5.17M |
| 4 |
Peloton Interactive
PTON
|
+$2.45M |
| 5 |
US Bancorp
USB
|
+$2.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.24% |
| 2 | Consumer Staples | 19.54% |
| 3 | Technology | 17.89% |
| 4 | Communication Services | 10.65% |
| 5 | Financials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Brady Corp
BRC
$4.44B
| – | – |
-97,904
| Closed | -$5.17M |
|
77
Stryker
SYK
$125B
| – | – |
-900
| Closed | -$221K |
|
78
Zymeworks
ZYME
$1.61B
| – | – |
-4,863
| Closed | -$230K |
|
|
UMPQ
79
DELISTED
Umpqua Holdings Corp
UMPQ
| – | – |
-23,013
| Closed | -$348K |
|
|
XLNX
80
DELISTED
Xilinx Inc
XLNX
| – | – |
-1,447
| Closed | -$205K |
|
Similar funds
RS
NED
CFG
CFG
TFP
AFS
WA
EMB
Prentiss Smith & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Prentiss Smith & Co held 80 positions worth $195M, down 7.2% from $210M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Prentiss Smith & Co withdrew a net $23.6M in Q1 2021, closing 6 positions and reducing 36 holdings. Its most notable exit was Brady Corp, an estimated $5.17M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Prentiss Smith & Co opened a new position in Dentsply Sirona worth $4.31M.
- Prentiss Smith & Co's largest Q1 2021 buy was Dentsply Sirona: 67,495 shares worth $4.31M.
- Prentiss Smith & Co added most to Regeneron Pharmaceuticals in Q1 2021, an estimated $2.39M increase.
- Prentiss Smith & Co's biggest Q1 2021 reduction was Idacorp, cutting an estimated $6.39M.
- Prentiss Smith & Co fully exited Brady Corp in Q1 2021, selling an estimated $5.17M.
- Prentiss Smith & Co's ten largest holdings make up 39% of its $195M portfolio in Q1 2021.
- Prentiss Smith & Co opened 3 new positions and closed 6 in Q1 2021.
- Prentiss Smith & Co's portfolio value fell 7.2% quarter-over-quarter to $195M.
Based on Prentiss Smith & Co's 13F filing for Q1 2021, filed 21 Jun 2021.